Insider Transactions in Q2 2022 at Vanda Pharmaceuticals Inc. (VNDA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2022
|
Phaedra Chrousos |
BUY
Grant, award, or other acquisition
|
Direct |
12,006
+32.5%
|
-
|
|
Jun 16
2022
|
Richard W Dugan |
BUY
Grant, award, or other acquisition
|
Direct |
12,006
+12.99%
|
-
|
|
Jun 16
2022
|
Stephen Ray Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
12,006
+39.33%
|
-
|
|
Jun 16
2022
|
Anne Sempowski Ward |
BUY
Grant, award, or other acquisition
|
Direct |
12,006
+35.3%
|
-
|
|
Jun 13
2022
|
Stephen Ray Mitchell |
SELL
Open market or private sale
|
Direct |
2,700
-29.3%
|
$24,300
$9.48 P/Share
|
|
Jun 02
2022
|
Thomas Watkins Director |
SELL
Open market or private sale
|
Direct |
6,441
-9.27%
|
$57,969
$9.9 P/Share
|
|
Jun 02
2022
|
Thomas Watkins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+17.75%
|
$60,000
$4.15 P/Share
|
|
May 31
2022
|
Richard W Dugan |
SELL
Open market or private sale
|
Direct |
6,500
-8.68%
|
$58,500
$9.85 P/Share
|
|
May 31
2022
|
Richard W Dugan |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+16.69%
|
$60,000
$4.15 P/Share
|